Looking at the REGN Regeneron Pharmaceuticals options chain ahead of earnings , I would buy the $730 strike price Puts with 2023-2-17 expiration date for about $16.53 premium. If the options turn out to be profitable Before the earnings release, I would sell at least 50%. Looking forward to read your opinion about it.
Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $74.451B Current Price: $685.94 Breakout price: $687.00 Buy Zone (Top/Bottom Range): $660.50-$603.40 Price Target: $812.00-$816.40 Estimated Duration to Target: 125-130d Contract of Interest: $REGN 9/16/22 700c Trade price as of publish...
*rising rates environment. Go small caps!! #MSOgang Large cap stonks & Crypto Ponzi Pogs collapse. Digi Dollar CBDC wins. Taxes will be paid!!!! Finally.
Stonk. #MSOgang small caps. Investing ain't easy. Rule # whatever, don't be cute. Vaccine play is overplayed. 2021 is not a repeat of '20. A rising rate environment is in works. $GNLN #thegem #cannabisreform
📌 REGN pipeline (with particular focus on the early stages) CEMIPLIMAB, REGN3767, REGN1979, REGN4018, REGN5458, REGN5459, REGN5678, REGN5093, REGN5713-5714-5715 and REGN-COV2 all have a lot of potential with particular focus around oncology. As can be see with GILD, the covid positioning has already moved on a lot: we are ready to play chapter II and REGN...
Hi guys, hope you are well. Today we will be looking at Regeneron, hopefully at this point you understand the basics of Elliot wave and my diagram should be easily explainable. Wave 1 formed nicely with Wave 2 becoming an ending diagonal triangle in a corrective structure. The beginning of wave 3 has formed, and the structure is perfect for an investment...
GILD - The Sleeping Giant - Trend Reversal ___________________ ENTRY = 56.56 Double Bottom - +64 confirmation 1st Target = .236fib@72.33 2nd Target = .382fib@82.08 3rd Target = .5fib@89.97 HOLD Target = .618@97.85+ JAN22 Call Leaps Still...
My last chart: November 22, 2020: Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA (The Motley Fool). Regeneron Covid Drug Gets Emergency OK. Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. (the street). If you are interested...
The above references an opinion and is for information purposes only. It is not intended to be investment advice. Seek a duly licensed professional for investment advice.
We expected a bounce and here we got one. It's really early in the trade but a good sign of beeing already in profit. On weakness, I will watch price action and maybe add to my position.
Regeneron is in a Trading - Range since nearly 1 year. I estimate a bounce.
Theres still about $25 Regeneron can fall before it would begin to retrace the so called "wave 1" momentum.
The bullish case for Regn